Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ajzner

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Orvosi Hetilap|February 23, 1997
[Thrombocyte dysfunction in children with albinism]Z Pap, E Ajzner, C Kiss, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleedingE Ajzner, I Balogh, G Haramura, et al.
The Journal of Bone and Joint Surgery. British Volume|May 6, 2004
The most severe forms of Perthes' disease associated with the homozygous Factor V Leiden mutationK Szepesi, E Pósán, J Hársfalvi, et al.
Thrombosis Research|January 13, 2000
Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet functionA Kerényi, A Schlammadinger, E Ajzner, et al.
Molecular Pharmacology|June 1, 1997
Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathwayZ Szondy, U Reichert, J M Bernardon, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 27, 2001
Natural coagulation inhibitor proteins in young patients with cerebral ischemiaL Oláh, M Misz, J Kappelmayer, et al.
Orvosi Hetilap|November 12, 1998
[Hemostatic abnormalities in ischemic stroke]M Misz, L Oláh, J Kappelmayer, et al.
Haematologia|June 7, 2000
Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutationN Regéczy, I Balogh, G Lakos, et al.
Molecular Syndromology|January 8, 2013
Mutational spectrum of smith-lemli-opitz syndrome patients in hungaryI Balogh, K Koczok, G P Szabó, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Orvosi Hetilap|February 23, 1997
[Thrombocyte dysfunction in children with albinism]Z Pap, E Ajzner, C Kiss, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleedingE Ajzner, I Balogh, G Haramura, et al.
The Journal of Bone and Joint Surgery. British Volume|May 6, 2004
The most severe forms of Perthes' disease associated with the homozygous Factor V Leiden mutationK Szepesi, E Pósán, J Hársfalvi, et al.
Thrombosis Research|January 13, 2000
Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet functionA Kerényi, A Schlammadinger, E Ajzner, et al.
Molecular Pharmacology|June 1, 1997
Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathwayZ Szondy, U Reichert, J M Bernardon, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 27, 2001
Natural coagulation inhibitor proteins in young patients with cerebral ischemiaL Oláh, M Misz, J Kappelmayer, et al.
Orvosi Hetilap|November 12, 1998
[Hemostatic abnormalities in ischemic stroke]M Misz, L Oláh, J Kappelmayer, et al.
Haematologia|June 7, 2000
Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutationN Regéczy, I Balogh, G Lakos, et al.
Molecular Syndromology|January 8, 2013
Mutational spectrum of smith-lemli-opitz syndrome patients in hungaryI Balogh, K Koczok, G P Szabó, et al.
Pageof 2